Work

Advances in LLM: Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma.

Year: 2012

Type: letter

Source: PubMed

Author: Nancy L Bartlett

Institution: Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2414585000

Cites:

Cited by:

Related to: 10